ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA.
about
ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
ACTR-05. THE RANDOMIZED PHASE ...... NEWLY DIAGNOSED GLIOBLASTOMA.
@en
ACTR-05. THE RANDOMIZED PHASE ...... NEWLY DIAGNOSED GLIOBLASTOMA.
@nl
type
label
ACTR-05. THE RANDOMIZED PHASE ...... NEWLY DIAGNOSED GLIOBLASTOMA.
@en
ACTR-05. THE RANDOMIZED PHASE ...... NEWLY DIAGNOSED GLIOBLASTOMA.
@nl
prefLabel
ACTR-05. THE RANDOMIZED PHASE ...... NEWLY DIAGNOSED GLIOBLASTOMA.
@en
ACTR-05. THE RANDOMIZED PHASE ...... NEWLY DIAGNOSED GLIOBLASTOMA.
@nl
P2093
P50
P356
P1433
P1476
ACTR-05. THE RANDOMIZED PHASE ...... NEWLY DIAGNOSED GLIOBLASTOMA.
@en
P2093
Adrian Ochsenbein
Andrea Schmid
Andreas Hottinger
Christian Riklin
Christoph Mancao
David Jones
Elisabeth Jane Rushing
Francesca Caparrotti
Francisca Joerger
Hans-Georg Wirsching
P304
P356
10.1093/NEUONC/NOX168.004
P433
P577
2017-11-06T00:00:00Z